Takeda Pharmaceuticals and Lundbeck have jointly announced the submission of a New Drug Application (NDA ... is under investigation as an antidepressant for the treatment of major depressive ...
Antidepressant consumption has skyrocketed in recent years in almost the entire world. In Spain, between 2020 and 2021, it grew by 10%, and in Mexico, the consumption of these drugs and anxiolytics ...
According to the National Institute of Mental Health (NIMH), more than one in five adults (about 20%) in the United States has a mental health condition. Treatments for mental health conditions are ...
21, 2024 — A device that delivers direct stimulation to the brain was found to be a safe and effective means of treating depression at home, according to a new ... Nov. 13, 2024 — New findings ...
Johnson & Johnson's Spravato therapy for treatment-resistant depression ... will look to the new data to try to encourage take-up. One issue has been the cost of the drug, with health technology ...